Ectoparasitic Infestations: Clinical Trials

23 trials for Ectoparasitic Infestations, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

17 completed, 3 unknown, 1 not yet recruiting, 1 recruiting. 23 Phase 3, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 323Completed 17, Unknown 3, Not yet recruiting 1, Recruiting 1, Terminated 1
Phase 23Completed 2, Terminated 1

Follow Ectoparasitic Infestations: new trials by email Literature Review of Ectoparasitic Infestations trials Research Report on Ectoparasitic Infestations

Trials (filtered) newest first · largest first

All 23 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Better Options for Lymphatic Filariasis Treatment
MoxDA - Moxidectin + Diethylcarbamzine (DEC) + Albendazole, IDA - Ivermectin + DEC + albendazole - Lymphatic Filariasis, Scabies
Phase 3RecruitingMedicines Development for Global Health51002026-09-282026-10-07
Therapy for Scabies With Two Differently Concentrated Permethrin Creams
5% Permethrin Creme, 10% Permethrin Creme - Scabies
Phase 3Not yet recruitingInfectopharm Arzneimittel GmbH2202024-05-012024-04-23
Sulfur vs. Different Regimes of Permethrin for Scabies
Permethrin Solution, Sulfur - Scabies
Phase 3CompletedDamascus University2502022-03-152024-05-02
Escalated Therapy of Scabies With INFECTOSCAB 5% (Permethrin)
InfectoScab 5 % Creme, Permethrin 10 % Creme, Driponin 3 mg Tabletten - Scabies
Phase 3UnknownInfectopharm Arzneimittel GmbH1832021-06-112021-08-26
Adjunctive Ivermectin Mass Drug Administration for Malaria Control
Ivermectin, Placebo, Dihydroartemisinin-piperaquine - Malaria,Falciparum, Neglected Tropical Diseases
Phase 3UnknownLondon School of Hygiene and Tropical Medicine240002021-05-032022-02-24
Safety of Co-administration of IDA and Azithromycin for NTDs ( ComboNTDs )
Albendazole on Day 1, Ivermectin on Day 1, Diethylcarbamazine on day 1 - Trachoma, Yaws
Phase 3CompletedLihir Medical Centre200002018-10-012019-02-28
A Bioequivalence Study With Clinical Endpoints to Evaluate the Safety and Therapeutic Equivalence of Permethrin Cream 5% & Elimite™ in Subjects With Scabies
Permethrin Cream 5% - Scabies
Phase 3CompletedSaptalis Pharmaceuticals LLC1262018-04-102020-10-23
Impact of Community Scabies Treatment on Head Lice Prevalence in the Solomon Islands
Ivermectin, Permethrin 5%, Malathion Shampoo 0.5% - Scabies, Head Lice
Phase 3CompletedLondon School of Hygiene and Tropical Medicine1182017-08-012019-06-14
Multiple-Site Study to Evaluate the Therapeutic Equivalence of Permethrin Cream, 5% in the Treatment of Scabies
Permethrin Cream, 5%, Elimite™ Cream (permethrin) 5% - Scabies
Phase 3CompletedEncube Ethicals Pvt. Ltd.2542017-06-012019-03-26
Phase 3 Trial to Assess the Safety and Efficacy of Natroba for the Treatment of Scabies
spinosad topical suspension, 0.9%, Placebo - Scabies
Phase 3CompletedParaPRO LLC2802017-05-102021-05-21
Phase 3 Trial to Assess the Safety and Efficacy of Natroba for the Treatment of Scabies
spinosad topical suspension, 0.9%, Placebo - Scabies
Phase 3CompletedParaPRO LLC2912017-05-022021-05-19
Bio-equivalence Study Comparing Permethrin Cream, 5% With Elimite in Patients With Active Scabies.
Permethrin Cream, 5%, Elimite - Scabies
Phase 3CompletedMayne Pharma International Pty Ltd1402016-11-012020-09-02
Oral Ivermectin Versus Topical Permethrin to Treat Scabies in Children and Adults
Ivermectin, Permethrin - Scabies
Phase 3CompletedUniversity Hospital, Bordeaux10922016-01-192024-06-17
A Study to Evaluate the Therapeutic Equivalence of Generic Permethrin Cream 5% to Elimite® in the Treatment of Scabies
Permethrin - Scabies
Phase 3CompletedDr. Reddy's Laboratories Limited2502015-09-012016-10-14
Efficacy and Safety Study for PIOLIN® Shampoo
PIOLIN®, NEDAX - PEDICULOSIS
Phase 3UnknownPhytopharm Consulting Brazil2122014-07-012013-10-23
Efficacy, Safety and Tolerability of a Novel Malathion Formulation in Patients 2 Years and Older With Head Lice
Malathion gel 0.5%, Permethrin 1% rinse (Nix Crème) - Pediculosis
Phase 3CompletedSun Pharmaceutical Industries, Inc.4032009-08-012014-06-13
Efficacy, Safety and Tolerability of a Novel Malathion Formulation in Patients 2 Years and Older With Head Lice
Malathion gel 0.5%, Permethrin 1% rinse - Pediculosis
Phase 3CompletedSun Pharmaceutical Industries, Inc.2542009-08-012014-08-04
Safety and Tolerability of a Novel Malathion Formulation in Children Age 6-24 Months With Head Lice
MALG (malathion) Treatment - Pediculosis
Phase 2 / Phase 3CompletedSun Pharmaceutical Industries, Inc.122008-09-012014-08-07
Safety and Efficacy Study of NatrOVA Creme Rinse - 1% and NIX Creme Rinse in Subjects 6 Months or Older With Head Lice
Spinosad, Permethrin 1% - Pediculosis
Phase 3CompletedParaPRO LLC5582007-09-012012-10-11
Safety and Efficacy of a Novel Malathion Formulation in the Treatment of Head Lice
MALG, Ovide (malathion) lotion 0.05%, Permethrin 1% - Lice Infestations
Phase 3CompletedSun Pharmaceutical Industries, Inc.3602005-12-012013-12-23

Showing 20 of 23. Sign in to see all of them.

Narrower conditions

Scabies (14)  ·  Lice Infestations (9)  ·  Elephantiasis, Filarial (3)  ·  Strongyloidiasis (3)  ·  Neglected Diseases (2)  ·  Ancylostomiasis (1)  ·  Malaria (1)  ·  Malaria, Falciparum (1)  ·  Parasitic Diseases (1)  ·  Skin Diseases (1)  ·  Skin Diseases, Infectious (1)  ·  Trachoma (1)  ·  Yaws (1)

Broader conditions

Infections (23)  ·  Skin Diseases, Parasitic (23)  ·  Skin and Connective Tissue Diseases (23)  ·  Parasitic Diseases (22)  ·  Skin Diseases (22)  ·  Skin Diseases, Infectious (22)  ·  Mite Infestations (14)  ·  Filariasis (3)  ·  Helminthiasis (3)  ·  Hemic and Lymphatic Diseases (3)  ·  Lymphatic Diseases (3)  ·  Lymphedema (3)  ·  Mosquito-Borne Diseases (3)  ·  Nematode Infections (3)

Interventions

Permethrin (8)  ·  Ivermectin (5)  ·  Malathion (3)  ·  Suspensions (3)  ·  spinosad (3)  ·  Albendazole (2)  ·  Azithromycin (1)  ·  Diethylcarbamazine (1)  ·  Sulfur (1)  ·  Therapeutics (1)  ·  coconut diethanolamide (1)

Sponsors

Sun Pharmaceutical Industries, Inc. (4)  ·  ParaPRO LLC (3)  ·  Infectopharm Arzneimittel GmbH (2)  ·  London School of Hygiene and Tropical Medicine (2)  ·  Damascus University (1)  ·  Dr. Reddy's Laboratories Limited (1)  ·  Encube Ethicals Pvt. Ltd. (1)  ·  Johnson & Johnson Consumer and Personal Products Worldwide (1)  ·  Lihir Medical Centre (1)  ·  Mayne Pharma International Pty Ltd (1)  ·  Medical Entomology Centre (1)  ·  Medicines Development for Global Health (1)  ·  Phytopharm Consulting Brazil (1)  ·  Saptalis Pharmaceuticals LLC (1)  ·  Uniquest Pty Ltd (1)

Countries

United States (11)  ·  El Salvador (2)  ·  France (2)  ·  Australia (1)  ·  Brazil (1)  ·  Fiji (1)  ·  Germany (1)  ·  Guadeloupe (1)  ·  Guinea-Bissau (1)  ·  Ireland (1)  ·  Israel (1)  ·  Panama (1)  ·  Papua New Guinea (1)  ·  Puerto Rico (1)  ·  Solomon Islands (1)

Top investigators

Kerry W Mettert, MBA (2)  ·  Anna R Last, MBChB PhD (1)  ·  Ashis Patnaik, MD (1)  ·  Bill Miller, MD (1)  ·  Bruneau Giraudeau, Doctor (1)  ·  Ian F Burgess (1)  ·  Jerry Cottrell (1)  ·  Lucy John, MD (1)  ·  Phoevos Hughes, JD (1)  ·  Prasanna Ganapathi, MD (1)  ·  Pratik Kamani (1)  ·  Shilpi Dhawan, MD (1)

Results publications

PMID 17845167, PMID 20220184, PMID 30252856, PMID 37419638, PMID 39551062, PMID 41494769

NIH funding

2019 (1), 2023 (1)